Paul T Nghiem

39PUBLICATIONS
141CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Apr 29, 2026
Immunotherapy Significantly Improves Merkel Cell Carcinoma-Specific Survival: A Single-Cohort Propensity Score-Matched Analysis.

|Mar 04, 2026
Response of B Cells Specific for Polyomavirus-Derived Oncoprotein Is Predictive of Merkel Cell Carcinoma Tumor Control.

Haroldo J Rodriguez Chevez, Allison J Remington, Matthew D Gray

|Dec 25, 2025
Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma.

Melissa M Yamada, Smitha Chandrasekhar, Ted A Gooley

|Oct 23, 2025
Circulating Neoantigen- and Viral Oncoprotein-Specific CD8+ T Cells Share a Transcriptional Signature.

Saumya Jani, Tomas Bencomo, Carolyn Shasha

|Sep 19, 2025
Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.

Peter Y Ch'en, Yuzheng Zhang, Daniel S Hippe

|Aug 11, 2025
Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Lisa Tachiki, Yasman Moshiri, Daniel S Hippe

Pageof 7

Frequent Collaborators

11 joint publications

Shailender Bhatia

9 joint publications

Tomoko Akaike

8 joint publications

Candice D Church

8 joint publications

David M Koelle